Insulin degludec is superior to sitagliptin in improving glycaemic control in uncontrolled patients with type 2 diabetes on oral agents

被引：0
|
作者：
Philis-Tsimikas, A. [1 ]
Del Prato, S. [2 ]
Satman, I. [3 ]
Bhargava, A. [4 ]
Dharmalingam, M. [5 ]
Skjoth, T. V. [6 ]
Rasmussen, S. [6 ]
Garber, A. J. [7 ]
机构：
[1] Scripps Whittier Diabet Inst, La Jolla, CA USA
[2] Univ Pisa, Dept Endocrinol & Metab, I-56100 Pisa, Italy
[3] Istanbul Univ, Istanbul Fac Med, Istanbul, Turkey
[4] Iowa Diabet & Endocrinol Res Ctr, Des Moines, IA USA
[5] Bangalore Endocrinol & Diabet Res Ctr, Bangalore, Karnataka, India
[6] Novo Nordisk AS, Soborg, Denmark
[7] Baylor Coll Med, Dept Med, Houston, TX 77030 USA
来源：
DIABETOLOGIA | 2012年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
40
引用
收藏
页码：S22 / S22
页数：1
相关论文
共 50 条
  • [1] Effect of insulin degludec versus sitagliptin in patients with type 2 diabetes uncontrolled on oral antidiabetic agents
    Philis-Tsimikas, A.
    Del Prato, S.
    Satman, I.
    Bhargava, A.
    Dharmalingam, M.
    Skjoth, T. V.
    Rasmussen, S.
    Garber, A. J.
    [J]. DIABETES OBESITY & METABOLISM, 2013, 15 (08): : 760 - 766
  • [2] Insulin Degludec is Superior to Sitagliptin in Improving Glycemic Control in Insulin-Naive Patients With Type 2 Diabetes
    Philis-Tsimikas, Athena
    Del Prato, Stefano
    Satman, Ilhan
    Bhargava, Anuj
    Dharmalingam, Mala
    Skjoth, Trine V.
    Rasmussen, Soren
    Garber, Alan J.
    [J]. DIABETES, 2012, 61 : A263 - A263
  • [3] Sitagliptin Monotherapy improved glycaemic control in patients with type 2 diabetes
    Aschner, P.
    Kipnes, M.
    Lunceford, J.
    Sanchez, M.
    Mickel, C.
    Davies, M. J.
    Williams-Herman, D.
    [J]. DIABETOLOGIA, 2006, 49 : 5 - 5
  • [4] Evening oral insulin (ORMD-0801) glycaemic effects in uncontrolled type 2 diabetes patients
    Eldor, R.
    Fleming, A.
    Neutel, J.
    Homer, K.
    Kidron, M.
    Rosenstock, J.
    [J]. DIABETOLOGIA, 2020, 63 (SUPPL 1) : S30 - S31
  • [5] Improving glycaemic control in patients with Type 2 diabetes mellitus without insulin therapy
    Goudswaard, AN
    Stolk, RP
    de Valk, HW
    Rutten, GEHM
    [J]. DIABETIC MEDICINE, 2003, 20 (07) : 540 - 544
  • [6] Treatment intensification with insulin degludec improves glycaemic control in patients with Type 2 diabetes treated with liraglutide and metformin
    Kumar, S.
    Aroda, V.
    Bailey, T.
    Cariou, B.
    Leiter, L.
    Raskin, P.
    Zacho, J.
    Philis-Tsimikas, A.
    [J]. DIABETIC MEDICINE, 2015, 32 : 66 - 66
  • [7] Inhaled insulin superior to rosiglitazone in patients with uncontrolled type 2 diabetes
    不详
    [J]. FORMULARY, 2003, 38 (07) : 408 - 408
  • [8] Postprandial glycaemic control in patients with Type 2 diabetes on a combination of insulin degludec and liraglutide vs each component individually
    Gough, S. C. L.
    Rodbard, H. W.
    Woo, V. C.
    Linjawi, S.
    Poulsen, P.
    Damgaard, L. H.
    Bode, B. W.
    [J]. DIABETIC MEDICINE, 2014, 31 : 51 - 51
  • [9] Switching to insulin degludec (IDeg) improves glycaemic control in patients with Type 2 diabetes in a real-world setting
    Feher, M.
    Tentolouris, N.
    Knudsen, S.
    Lapolla, A.
    Prager, R.
    Phan, T. M.
    Wolden, M. L.
    Schultes, B.
    [J]. DIABETIC MEDICINE, 2018, 35 : 203 - 203
  • [10] Glucometrics and glycaemic control in adults with type 1 diabetes when switching to insulin degludec
    Charleer, S.
    De Groote, R.
    Lefever, E.
    Donne, P.
    De Block, C.
    Mathieu, C.
    Gillard, P.
    [J]. DIABETOLOGIA, 2023, 66 (SUPPL 1) : S394 - S395
12345